Kajikawa H, Hosokawa S, Kameoka H, Nishimoto N, Miyoshi S, Iwao N, Mizutani S
Jpn J Antibiot. 1984 Aug;37(8):1453-69.
A second part of our continuous investigation on the clinical effect of cefaclor (CCL) against urinary tract infections was reported herein. CCL, a daily dose of 0.75 g t.i.d., has been applied for the treatment of (I) 76 cases with the uncomplicated acute cystitis in the women, and (II) 55 cases with the complicated. Rates of effectiveness were obtained 98.7% in (I) and 60% in (II). Side effects were noted in 13 cases out of total 150 cases.
本文报道了我们关于头孢克洛(CCL)治疗尿路感染临床效果的持续研究的第二部分。CCL每日剂量0.75g,每日三次,已用于治疗:(I)76例女性单纯性急性膀胱炎患者,以及(II)55例复杂性患者。(I)组有效率为98.7%,(II)组为60%。150例患者中13例出现副作用。